U-M's multicultural health initiatives foster understanding to help patients get the care they need.
Phase 1 clinical trials offer options when standard treatment isn't a choice
Volunteer for research at UMClinicalStudies.org
Site offers sound advice on phony cancer cures
What to Expect When Tube Feeding is Necessary
Behind the waiting room walls in the U-M Cancer Center
When Teresa Singh was diagnosed with non-Hodgkin's lymphoma in 1996, her oncologist recommended the standard course of treatment: a combination of chemotherapy and radiation. But in researching her disease, Singh learned the likelihood of her cancer returning within 18 months was high. And if a recurrence was treated successfully, it was still likely to come back yet again. Standard treatment just didn't seem like the right choice for Singh, so she started looking for other options.
Study seeks better ways to care for breast cancer survivors